Hodgkin lymphoma

News

Assessing Frequency of Secondary Malignancies in Survivors of Hodgkin Lymphoma

06/17/2020

A single institution study conducted at the Ospedale Oncologico di Riferimento Regionale (Italy) provided data on the cumulative incidence of secondary malignancies after treatment for Hodgkin lymphoma.

A single institution study...

06/17/2020

Journal of Clinical Pathways

News

Comparative Effectiveness of Monotherapies for Relapsed, Refractory Hodgkin Lymphoma

05/14/2020

In patients with relapsed or refractory classic Hodgkin lymphoma, pembrolizumab may be superior to brentuximab vedotin and provide statistically significant and clinically meaningful improvement in PFS across all subgroups.

In patients with relapsed or...

05/14/2020

Journal of Clinical Pathways

Research in Review

Early PET Scan Improves Outcomes for Patients With Hodgkin Lymphoma

06/08/2017

JCP Editors

Response to positron emission tomography (PET) scan after two cycles of standard treatment allows for early treatment adaption for patients with early-stage Hodgkin lymphoma, according to research published in the...

...

06/08/2017

Journal of Clinical Pathways

Research in Review

Radiation Therapy Significantly Increases Survival in Type of B-Cell Malignancy

05/31/2017

JCP Editors

Patients with Hodgkin lymphoma who are treated with radiation therapy are more likely to survive the disease than those not treated with radiation therapy, according to a recent study published in Anticancer Research...

...

05/31/2017

Journal of Clinical Pathways

Research in Review

Increased Risk of Secondary Cancer for Survivors of Hodgkin Lymphoma

05/19/2017

JCP Editors

Survivors of Hodgkin lymphoma with a family history of cancer have a 1.3-fold higher risk of developing a second cancer, according to research published in the Journal of Clinical Oncology (May...

...

05/19/2017

Journal of Clinical Pathways

Research in Review

Risk-Adapted Therapy Reduces Treatment Toxicity for Patients With Hodgkin Lymphoma

05/19/2017

JCP Editors

A combined chemotherapy approach may eliminate the toxic effects of radiation therapy in children and young adults with Hodgkin lymphoma, according to early results of a study that will be presented at the 2017 ASCO...

A...

05/19/2017

Journal of Clinical Pathways

Research in Review

Risk-Adapted Therapy Recommended for Patients With Hodgkin Lymphoma

04/27/2017

JCP Editors

Long-term follow-up data from multiple studies support the current risk-adapted therapeutic strategies in early-stage Hodgkin lymphoma, according to research published in the Journal of Clinical Oncology (published...

...

04/27/2017

Journal of Clinical Pathways

Adolescent Hodgkin Lymphoma Patients Not Receiving Optimal Follow-up Care

01/18/2016

JCP Editors

Adolescent and young adult (AYAs) survivors of Hodgkin lymphoma may not be receiving the recommended post-treatment care, according to a recent study. Cancer is the leading cause of death in AYAs, and Hodgkin...

...

01/18/2016

Journal of Clinical Pathways